Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05463198 · ClinicalTrials.gov registry record · NA
Evaluation of Physiological Variables and Detection of Blood Loss Using the Zynex Fluid Monitoring System, Model CM-1600
A NA study, sponsored by Zynex Monitoring Solutions.
- Completed
- Registry status
- NA
- Development phase
- 351
- Enrollment target
NCT05463198 is a NA study that has completed, run by Zynex Monitoring Solutions. The registered enrollment target is 351 participants.
The verdict
NCT05463198, a NA study, has completed, sponsored by Zynex Monitoring Solutions.
- COMPLETED
- Registry status
- NA
- Development phase
- 351 participants
- Enrollment target
Study Summary
The study is a prospective, non-randomized, non-blinded, non-significant risk, multi-center study enrolling up to 500 healthy adult subjects consented to undergo a whole blood donation procedure. The study will involve enrolling subjects that will undergo blood donation wearing the study device (CM-1600 Device) and capture study-required physiological parameters pre-, during, and post-donation.
Interventions
- DEVICE CM-1600
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 351 participants |
| Start Date | 2022-09-14 |
| Est. Completion | 2023-05-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05463198
The ClinicalTrials.gov registry entry for NCT05463198 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 351 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Zynex Monitoring Solutions, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CM-1600 is the first listed.
NCT05463198 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05463198 about?
NCT05463198 is a clinical study titled "Evaluation of Physiological Variables and Detection of Blood Loss Using the Zynex Fluid Monitoring System, Model CM-1600". The study is a prospective, non-randomized, non-blinded, non-significant risk, multi-center study enrolling up to 500 healthy adult subjects consented to undergo a whole blood donation procedure. The study will involve enrolling subjects that will undergo blood donation wearing the study device (CM-...
What is the current status of trial NCT05463198?
This trial is currently completed. It is a NA study. The enrollment target is 351 participants. The study started on 2022-09-14. Estimated completion is 2023-05-26.
What interventions are being tested in trial NCT05463198?
The interventions under investigation include: CM-1600 (DEVICE).
Who is sponsoring clinical trial NCT05463198?
This trial is sponsored by Zynex Monitoring Solutions, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.